Showing results (1-10 of 498) with videos related to

Sort By:
Pageof 50
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|September 28, 2019
Biomarkers as Surrogate Endpoints: Ongoing Opportunities for ValidationAudrey D Zhang, Joseph S Ross
The Milbank Quarterly|July 16, 2019
Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015Audrey D Zhang, Jason L Schwartz, Joseph S Ross
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 8, 2025
FDA Advisory Committee Review of Supplemental Indications and Reasons for Non-Approval, 2008-2022Audrey D Zhang, Nikhil Chaudhry, Reshma Ramachandran, et al.
Clinical Trials (London, England)|April 17, 2021
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Joshua J Skydel, Audrey D Zhang, Sanket S Dhruva, et al.
JAMA Network Open|June 10, 2021
Characteristics of Clinical Studies Used for US Food and Drug Administration Supplemental Indication Approvals of Drugs and Biologics, 2017 to 2019Meera Dhodapkar, Audrey D Zhang, Jeremy Puthumana, et al.
JAMA Network Open|April 22, 2020
Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017Audrey D Zhang, Jeremy Puthumana, Nicholas S Downing, et al.
BMJ Evidence-Based Medicine|November 10, 2022
Consistency between trials presented at conferences, their subsequent publications and press releasesAnisa Rowhani-Farid, Kyungwan Hong, Mikas Grewal, et al.
JAMA Network Open|May 6, 2021
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic ReviewAaron S Long, Audrey D Zhang, Caitlin E Meyer, et al.
Scientific Data|August 8, 2023
Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health modelsAnisa Rowhani-Farid, Mikas Grewal, Steven Solar, et al.
Systematic Reviews|September 22, 2016
Clinical research data sharing: what an open science world means for researchers involved in evidence synthesisJoseph S Ross
Pageof 50